Xiga Met 5/1000mg Tablet

Xiga Met 5/1000mg Tablet is a combination medication containing two active ingredients: Dapagliflozin and Metformin. This tablet is prescribed for the management of type 2 diabetes mellitus. Dapagliflozin belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, while Metformin is a biguanide antidiabetic agent. This combination medication works by targeting different mechanisms to improve glycemic control in individuals with type 2 diabetes.

Uses:

• Xiga Met 5/1000mg Tablet is indicated for the treatment of type 2 diabetes mellitus in adults.
• The combination of Dapagliflozin and Metformin helps to lower blood sugar levels by increasing urinary glucose excretion and reducing hepatic glucose production.
• It is prescribed as an adjunct to diet and exercise to improve glycemic control in patients with diabetes who are not adequately controlled with either Dapagliflozin or Metformin alone.

Side Effects:

• Common side effects of Xiga Met 5/1000mg Tablet may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal discomfort, and loss of appetite.
• Other potential side effects may include urinary tract infections, genital yeast infections, increased urination, thirst, dizziness, and low blood pressure.
• Rare but serious side effects may include lactic acidosis (a rare but serious metabolic complication of Metformin) and ketoacidosis (a serious complication of diabetes characterized by high levels of ketones in the blood).

Precautions:

• Patients with a history of hypersensitivity to Dapagliflozin, Metformin, or any other components of Xiga Met 5/1000mg Tablet should avoid its use.
• Caution is advised in individuals with impaired renal function, as both Dapagliflozin and Metformin may affect renal function.
• It is essential to monitor renal function, electrolyte levels, and blood glucose levels regularly during treatment with this medication.
• Patients should stay adequately hydrated to reduce the risk of dehydration and hypotension.

When Not to Use:

• Xiga Met 5/1000mg Tablet should not be used in patients with type 1 diabetes mellitus.
• It is contraindicated in individuals with severe renal impairment (eGFR less than 30 mL/min/1.73 m²) or end-stage renal disease requiring dialysis.
• Pregnant and breastfeeding women should avoid using this medication due to limited safety data.

FAQs:

1. What is the recommended dosage of Xiga Met 5/1000mg Tablet?
   • The usual recommended dose is one tablet once daily, with or without food. Dosage adjustments may be necessary based on individual patient characteristics and renal function.
2. Can Xiga Met 5/1000mg Tablet be used in combination with other antidiabetic medications?
   • Xiga Met 5/1000mg Tablet is a combination medication containing Dapagliflozin and Metformin. It can be used alone or in combination with other antidiabetic agents to improve glycemic control.
3. Is Xiga Met 5/1000mg Tablet suitable for all patients with type 2 diabetes mellitus?
   • No, Xiga Met 5/1000mg Tablet is contraindicated in certain patient populations, including those with severe renal impairment or type 1 diabetes mellitus. It is essential to consult with a healthcare professional before initiating treatment.
4. What are the common side effects of Xiga Met 5/1000mg Tablet?
   • Common side effects may include gastrointestinal disturbances, urinary tract infections, genital yeast infections, increased urination, thirst, dizziness, and low blood pressure. If any side effects persist or worsen, it is advisable to seek medical attention.
5. Is Xiga Met 5/1000mg Tablet safe for use during pregnancy and breastfeeding?
   • No, Xiga Met 5/1000mg Tablet should be avoided during pregnancy and breastfeeding due to limited safety data. Pregnant or breastfeeding women should discuss alternative treatment options with their healthcare provider.